| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |